[Analysis of prognostic factors in patients with acute coronary syndrome complicated with moderate to severe chronic kidney disease after percutaneous coronary intervention].

Q3 Medicine
北京大学学报(医学版) Pub Date : 2026-10-18
Jingda Cui, Fangfang Wang, Dan Li, Lijie Sun, Baoxia Chen, Jiangli Han
{"title":"[Analysis of prognostic factors in patients with acute coronary syndrome complicated with moderate to severe chronic kidney disease after percutaneous coronary intervention].","authors":"Jingda Cui, Fangfang Wang, Dan Li, Lijie Sun, Baoxia Chen, Jiangli Han","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the prognostic factors of patients with acute coronary syndrome (ACS) complicated with moderate to severe chronic kidney disease (CKD) after percutaneous coronary intervention (PCI) and to establish a risk predictive model.</p><p><strong>Methods: </strong>The medical records of 148 ACS patients with moderate to severe CKD who received PCI in the Department of Cardiology, Peking University Third Hospital from September 2021 to January 2023 and completed 12-month follow-up were retrospectively analyzed. According to whether the patients had a major adverse cardiovascular disease (MACE) 12 months after PCI, they were divided into MACE group and non-MACE group. Binary Logistic regression analysis was performed on the general clinical data, clinical test results, echocardiography, coronary angiography and PCI data of the two groups of patients, the prognostic factors were analyzed by backward stepwise regression, and the risk prediction model was established. The receiver operating characteristic (ROC) curve was drawn to test the predictive efficiency of the model.</p><p><strong>Results: </strong>A total of 148 patients with ACS combined with moderate to severe CKD were included in the study, including 50 patients in the MACE group and 98 patients in the non-MACE group, and the incidence of MACE 12 months after PCI was 33.8%.Binary Logistic analysis of hospitalization data of the two groups showed that white blood cell (<i>OR</i>=1.145; 95%<i>CI</i>: 1.017-1.290; <i>P</i>=0.026), age (<i>OR</i>=1.032; 95%<i>CI</i>: 1.001-1.065; <i>P</i>=0.046) and left ventricular ejection fraction (LVEF; <i>OR</i>=0.962; 95%<i>CI:</i> 0.934-0.990; <i>P</i>=0.009) were independent influencing factors for MACE 12 months after PCI (<i>P</i> < 0.05), CKD stage was not associated with the occurrence of MACE 12 months after PCI. The risk prediction model for MACE was Logit(<i>P</i>) = 0.032× age +0.136× leukocyte-0.039×LVEF. ROC curve analysis showed that this model had good prediction efficiency, and the area under the curve (AUC) predicted by the prediction model was 0.749, 95%<i>CI</i> was 0.666 to 0.832. The sensitivity and specificity were 72% and 68%.</p><p><strong>Conclusion: </strong>The incidence of MACE was higher in ACS patients with moderate to severe CKD 12 months after PCI, and white blood cells, age and LVEF were independent factors influencing the occurrence of MACE in these patients after PCI.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"58 5","pages":"980-986"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13672218/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the prognostic factors of patients with acute coronary syndrome (ACS) complicated with moderate to severe chronic kidney disease (CKD) after percutaneous coronary intervention (PCI) and to establish a risk predictive model.

Methods: The medical records of 148 ACS patients with moderate to severe CKD who received PCI in the Department of Cardiology, Peking University Third Hospital from September 2021 to January 2023 and completed 12-month follow-up were retrospectively analyzed. According to whether the patients had a major adverse cardiovascular disease (MACE) 12 months after PCI, they were divided into MACE group and non-MACE group. Binary Logistic regression analysis was performed on the general clinical data, clinical test results, echocardiography, coronary angiography and PCI data of the two groups of patients, the prognostic factors were analyzed by backward stepwise regression, and the risk prediction model was established. The receiver operating characteristic (ROC) curve was drawn to test the predictive efficiency of the model.

Results: A total of 148 patients with ACS combined with moderate to severe CKD were included in the study, including 50 patients in the MACE group and 98 patients in the non-MACE group, and the incidence of MACE 12 months after PCI was 33.8%.Binary Logistic analysis of hospitalization data of the two groups showed that white blood cell (OR=1.145; 95%CI: 1.017-1.290; P=0.026), age (OR=1.032; 95%CI: 1.001-1.065; P=0.046) and left ventricular ejection fraction (LVEF; OR=0.962; 95%CI: 0.934-0.990; P=0.009) were independent influencing factors for MACE 12 months after PCI (P < 0.05), CKD stage was not associated with the occurrence of MACE 12 months after PCI. The risk prediction model for MACE was Logit(P) = 0.032× age +0.136× leukocyte-0.039×LVEF. ROC curve analysis showed that this model had good prediction efficiency, and the area under the curve (AUC) predicted by the prediction model was 0.749, 95%CI was 0.666 to 0.832. The sensitivity and specificity were 72% and 68%.

Conclusion: The incidence of MACE was higher in ACS patients with moderate to severe CKD 12 months after PCI, and white blood cells, age and LVEF were independent factors influencing the occurrence of MACE in these patients after PCI.

[急性冠状动脉综合征合并中重度慢性肾病患者经皮冠状动脉介入治疗后预后因素分析]。
目的:探讨急性冠脉综合征(ACS)合并中重度慢性肾脏疾病(CKD)患者经皮冠状动脉介入治疗(PCI)后的预后影响因素,并建立风险预测模型。方法:回顾性分析北京大学第三医院心内科2021年9月至2023年1月接受PCI治疗的148例ACS合并中重度CKD患者12个月随访的病历。根据患者PCI术后12个月是否发生重大不良心血管疾病(MACE)分为MACE组和非MACE组。对两组患者的一般临床资料、临床检查结果、超声心动图、冠状动脉造影及PCI资料进行二元Logistic回归分析,采用反向逐步回归分析影响预后的因素,建立风险预测模型。绘制受试者工作特征(ROC)曲线,检验模型的预测效果。结果:共纳入148例ACS合并中重度CKD患者,其中MACE组50例,非MACE组98例,PCI术后12个月MACE发生率为33.8%。两组住院资料的二元Logistic分析显示,白细胞(OR=1.145, 95%CI: 1.017 ~ 1.290, P=0.026)、年龄(OR=1.032, 95%CI: 1.001 ~ 1.065, P=0.046)、左心室射血分数(LVEF, OR=0.962, 95%CI: 0.934 ~ 0.990, P=0.009)是PCI术后12个月MACE发生的独立影响因素(P < 0.05), CKD分期与PCI术后12个月MACE的发生无相关性。MACE的风险预测模型为Logit(P) = 0.032×年龄+0.136× leukocyte-0.039×LVEF。ROC曲线分析表明,该模型具有较好的预测效率,预测模型预测的曲线下面积(AUC)为0.749,95%CI为0.666 ~ 0.832。敏感性和特异性分别为72%和68%。结论:ACS合并中重度CKD患者PCI术后12个月MACE发生率较高,白细胞、年龄、LVEF是影响这些患者PCI术后MACE发生的独立因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
北京大学学报(医学版)
北京大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
9815
期刊介绍: Beijing Da Xue Xue Bao Yi Xue Ban / Journal of Peking University (Health Sciences), established in 1959, is a national academic journal sponsored by Peking University, and its former name is Journal of Beijing Medical University. The coverage of the Journal includes basic medical sciences, clinical medicine, oral medicine, surgery, public health and epidemiology, pharmacology and pharmacy. Over the last few years, the Journal has published articles and reports covering major topics in the different special issues (e.g. research on disease genome, theory of drug withdrawal, mechanism and prevention of cardiovascular and cerebrovascular diseases, stomatology, orthopaedic, public health, urology and reproductive medicine). All the topics involve latest advances in medical sciences, hot topics in specific specialties, and prevention and treatment of major diseases. The Journal has been indexed and abstracted by PubMed Central (PMC), MEDLINE/PubMed, EBSCO, Embase, Scopus, Chemical Abstracts (CA), Western Pacific Region Index Medicus (WPR), JSTChina, and almost all the Chinese sciences and technical index systems, including Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Science Citation Database (CSCD), China BioMedical Bibliographic Database (CBM), CMCI, Chinese Biological Abstracts, China National Academic Magazine Data-Base (CNKI), Wanfang Data (ChinaInfo), etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书